Metformin, a drug used in type 2-diabetes might have the potential to also act against Alzheimer’s disease. This has been shown in a study from scientists of the German Center for Neurodegenerative Diseases (DZNE), the University of Dundee and the Max-Planck-Institute for Molecular Genetics. The researchers have found out that the diabetes drug metformin counteracts alterations of the cell structure protein Tau in mice nerve cells. Read the rest of this entry »
Alzheimer’s Patients Could Benefit From Diabetes Drug
November 26th, 2010
New Strategies For Treating Diseases And Illnesses Such As Cancer And Flu
November 25th, 2010
Biochemist and protein crystallographer Dr. Oliver Daumke of the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, has won the “Bayer Early Excellence in Science Award 2010″ in the biology category. He will receive the prize worth EUR 10,000 for his contributions to the understanding of the structure and function of GTP-binding (G) proteins next spring in Berlin. Together with him, two other scientists, Professor Read the rest of this entry »
Abbott Announces Positive Results From Phase 2 Study Of Low Dose Atrasentan For Treatment Of Diabetic Kidney Disease
November 23rd, 2010
Abbott (NYSE: ABT) announced positive results from a Phase 2 dose-ranging study of atrasentan, a highly selective endothelin A receptor antagonist in development to help slow chronic kidney disease (CKD) progression in patients with type 2 diabetic nephropathy (diabetic kidney disease). Study results suggest that atrasentan, used in conjunction with renin-angiotensin system (RAS) inhibitors, may reduce albuminuria (presence of Read the rest of this entry »
Diabetes or Prediabetes Predicted for Half of Americans by 2020
November 23rd, 2010Unless significant changes are made‚ more than half of all Americans could have diabetes or prediabetes by the year 2020‚ according to a new analysis by UnitedHealth Group’s Center for Health Reform and Modernization.
Without a major change in health trends‚ this will have a cumulative cost of $3.35 trillion. Researchers also say that diabetes and prediabetes will account for an estimated 10 percent of total healthcare spending by Read the rest of this entry »
FTC Warns of Alleged Organ Scam
November 22nd, 2010According to the United Network for Organ Sharing, the Federal Trade Commission (FTC) recently received notification of an alleged scam whereby patients waiting for an organ transplant are contacted by phone and requested to provide money in exchange for receiving a donor organ. It is unlawful to buy and sell organs for transplant in the United States.
If you are contacted and requested to provide money to obtain a donor organ, please contact Read the rest of this entry »